Epithelial cell adhesion molecule-targeted drug delivery for cancer therapy
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epithelial cell adhesion molecule-targeted drug delivery for cancer therapy
Authors
Keywords
-
Journal
Expert Opinion on Drug Delivery
Volume 10, Issue 4, Pages 451-468
Publisher
Informa Healthcare
Online
2013-01-15
DOI
10.1517/17425247.2013.759938
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer
- (2012) M. Schmidt et al. ANNALS OF ONCOLOGY
- Preclinical Evaluation of VB6-845: An Anti-EpCAM Immunotoxin with Reduced Immunogenic Potential
- (2012) Joycelyn Entwistle et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- A Phase II Study of Trastuzumab Emtansine in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Who Were Previously Treated With Trastuzumab, Lapatinib, an Anthracycline, a Taxane, and Capecitabine
- (2012) Ian E. Krop et al. JOURNAL OF CLINICAL ONCOLOGY
- Sustained and cancer cell targeted cytosolic delivery of Onconase results in potent antitumor effects
- (2012) Hong Liang Zhao et al. JOURNAL OF CONTROLLED RELEASE
- Therapeutic Potential of Amanitin-Conjugated Anti-Epithelial Cell Adhesion Molecule Monoclonal Antibody Against Pancreatic Carcinoma
- (2012) Gerhard Moldenhauer et al. JNCI-Journal of the National Cancer Institute
- High Interstitial Fluid Pressure Is Associated with Low Tumour Penetration of Diagnostic Monoclonal Antibodies Applied for Molecular Imaging Purposes
- (2012) Markus Heine et al. PLoS One
- Facile Double-Functionalization of Designed Ankyrin Repeat Proteins using Click and Thiol Chemistries
- (2011) Manuel Simon et al. BIOCONJUGATE CHEMISTRY
- Pivotal role of epithelial cell adhesion molecule in the survival of lung cancer cells
- (2011) Tetsunari Hase et al. CANCER SCIENCE
- RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule
- (2011) Sarah Shigdar et al. CANCER SCIENCE
- Epithelial cell adhesion molecule expression (CD326) in cancer: A short review
- (2011) Carlo Patriarca et al. CANCER TREATMENT REVIEWS
- EpCAM/CD3-Bispecific T-cell Engaging Antibody MT110 Eliminates Primary Human Pancreatic Cancer Stem Cells
- (2011) M. Cioffi et al. CLINICAL CANCER RESEARCH
- DARPins and other repeat protein scaffolds: advances in engineering and applications
- (2011) Ykelien L Boersma et al. CURRENT OPINION IN BIOTECHNOLOGY
- Investigational antibody drug conjugates for solid tumors
- (2011) Puja Sapra et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- A guide to taming a toxin - recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer
- (2011) John E. Weldon et al. FEBS Journal
- EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis
- (2011) Gilbert Spizzo et al. JOURNAL OF CLINICAL PATHOLOGY
- DARPins Recognizing the Tumor-Associated Antigen EpCAM Selected by Phage and Ribosome Display and Engineered for Multivalency
- (2011) Nikolas Stefan et al. JOURNAL OF MOLECULAR BIOLOGY
- Ep-CAM is a significant prognostic factor in pancreatic cancer patients by suppressing cell activity
- (2011) H Akita et al. ONCOGENE
- Development of a GMP Phase III purification process for VB4-845, an immunotoxin expressed in E. coli using high cell density fermentation
- (2011) Arjune Premsukh et al. PROTEIN EXPRESSION AND PURIFICATION
- Cellular Uptake of Ribonuclease A Relies on Anionic Glycans
- (2010) Tzu-Yuan Chao et al. BIOCHEMISTRY
- Pharmacokinetics, immunogenicity and bioactivity of the therapeutic antibody catumaxomab intraperitoneally administered to cancer patients
- (2010) Peter Ruf et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Side-by-side analysis of five clinically tested anti-EpCAM monoclonal antibodies
- (2010) Markus Münz et al. Cancer Cell International
- Antibody-Maytansinoid Conjugates Designed to Bypass Multidrug Resistance
- (2010) Y. V. Kovtun et al. CANCER RESEARCH
- H3K9 Histone Methyltransferase G9a Promotes Lung Cancer Invasion and Metastasis by Silencing the Cell Adhesion Molecule Ep-CAM
- (2010) M.-W. Chen et al. CANCER RESEARCH
- A Novel Fusion Toxin Derived from an EpCAM-Specific Designed Ankyrin Repeat Protein Has Potent Antitumor Activity
- (2010) P. Martin-Killias et al. CLINICAL CANCER RESEARCH
- Antibody–drug conjugates: targeted drug delivery for cancer
- (2010) Stephen C Alley et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Adecatumumab: an anti-EpCAM monoclonal antibody, from the bench to the bedside
- (2010) Jean-Emmanuel Kurtz et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- EpCAM- and EGFR-targeted selective gene therapy for biliary cancers using Z33-fiber-modified adenovirus
- (2010) Rei Kawashima et al. INTERNATIONAL JOURNAL OF CANCER
- Phase II Study of the Antibody Drug Conjugate Trastuzumab-DM1 for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2) –Positive Breast Cancer After Prior HER2-Directed Therapy
- (2010) Howard A. Burris et al. JOURNAL OF CLINICAL ONCOLOGY
- Her2-specific Multivalent Adapters Confer Designed Tropism to Adenovirus for Gene Targeting
- (2010) Birgit Dreier et al. JOURNAL OF MOLECULAR BIOLOGY
- Maytansine and Cellular Metabolites of Antibody-Maytansinoid Conjugates Strongly Suppress Microtubule Dynamics by Binding to Microtubules
- (2010) M. Lopus et al. MOLECULAR CANCER THERAPEUTICS
- Cell-Specific Aptamer-Mediated Targeted Drug Delivery
- (2010) Jiehua Zhou et al. OLIGONUCLEOTIDES
- Phase II Study of the Human Anti-Epithelial Cell Adhesion Molecule Antibody Adecatumumab in Prostate Cancer Patients with Increasing Serum Levels of Prostate-Specific Antigen after Radical Prostatectomy
- (2010) Norbert Marschner et al. UROLOGIA INTERNATIONALIS
- An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer
- (2009) M. Schmidt et al. ANNALS OF ONCOLOGY
- Initial activation of EpCAM cleavage viacell-to-cell contact
- (2009) Sabine Denzel et al. BMC CANCER
- The Emerging Role of EpCAM in Cancer and Stem Cell Signaling
- (2009) M. Munz et al. CANCER RESEARCH
- Radiofrequency Ablation Combined with KS-IL2 Immunocytokine (EMD 273066) Results in an Enhanced Antitumor Effect against Murine Colon Adenocarcinoma
- (2009) E. E. Johnson et al. CLINICAL CANCER RESEARCH
- Generating Aptamers for Recognition of Virus-Infected Cells
- (2009) Z. Tang et al. CLINICAL CHEMISTRY
- ErbB receptors and signaling pathways in cancer
- (2009) Nancy E Hynes et al. CURRENT OPINION IN CELL BIOLOGY
- Cross-species Binding Analyses of Mouse and Human Neonatal Fc Receptor Show Dramatic Differences in Immunoglobulin G and Albumin Binding
- (2009) Jan Terje Andersen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Adjuvant Therapy With the Monoclonal Antibody Edrecolomab Plus Fluorouracil-Based Therapy Does Not Improve Overall Survival of Patients With Stage III Colon Cancer
- (2009) Anthony L.A. Fields et al. JOURNAL OF CLINICAL ONCOLOGY
- When Wishful Thinking Leads to a Misty-Eyed Appraisal: The Story of the Adjuvant Colon Cancer Trials With Edrecolomab
- (2009) Hans-Joachim Schmoll et al. JOURNAL OF CLINICAL ONCOLOGY
- Engineering and Biological Characterization of VB6-845, an Anti-EpCAM Immunotoxin Containing a T-cell Epitope-depleted Variant of the Plant Toxin Bouganin
- (2009) Jeannick Cizeau et al. JOURNAL OF IMMUNOTHERAPY
- A modeling analysis of the effects of molecular size and binding affinity on tumor targeting
- (2009) M. M. Schmidt et al. MOLECULAR CANCER THERAPEUTICS
- EpCAM-targeted delivery of nanocomplexed siRNA to tumor cells with designed ankyrin repeat proteins
- (2009) J. Winkler et al. MOLECULAR CANCER THERAPEUTICS
- Nuclear signalling by tumour-associated antigen EpCAM
- (2009) Dorothea Maetzel et al. NATURE CELL BIOLOGY
- In vivo selection of tumor-targeting RNA motifs
- (2009) Jing Mi et al. Nature Chemical Biology
- Antibody-Drug Conjugates for Cancer Therapy
- (2008) Paul J. Carter et al. CANCER JOURNAL
- Prognostic Effect of Epithelial Cell Adhesion Molecule Overexpression in Untreated Node-Negative Breast Cancer
- (2008) M. Schmidt et al. CLINICAL CANCER RESEARCH
- Evasion of Ribonuclease Inhibitor as a Determinant of Ribonuclease Cytotoxicity
- (2008) Thomas Rutkoski et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer
- (2008) F. Anthony Greco et al. LUNG CANCER
- An immunotoxin with greatly reduced immunogenicity by identification and removal of B cell epitopes
- (2008) M. Onda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EpCAM expression in normal, non-pathological tissues
- (2007) Eva Schmelzer Frontiers in Bioscience-Landmark
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now